Richard Hildreth

1.0k total citations
11 papers, 807 citations indexed

About

Richard Hildreth is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Richard Hildreth has authored 11 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in Richard Hildreth's work include MicroRNA in disease regulation (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and CAR-T cell therapy research (2 papers). Richard Hildreth is often cited by papers focused on MicroRNA in disease regulation (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and CAR-T cell therapy research (2 papers). Richard Hildreth collaborates with scholars based in United States, Russia and Panama. Richard Hildreth's co-authors include Curt I. Civin, Sebastien Morisot, Jonathan K. Alder, Robert W. Georgantas, Shelly Heimfeld, Carlo M. Croce, Chang‐Gong Liu, George A. Calin, Ian M. Kaplan and Michael A. McDevitt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Richard Hildreth

11 papers receiving 795 citations

Peers

Richard Hildreth
Linda Hanlon United Kingdom
Evangelos Pefanis United States
Ennan Guan United States
Vernon M. Coffield United States
Sabine Hahn Germany
Dona N. Ho Hong Kong
Heather Sheppard United States
Richard Hildreth
Citations per year, relative to Richard Hildreth Richard Hildreth (= 1×) peers Gitta Anne Heinz

Countries citing papers authored by Richard Hildreth

Since Specialization
Citations

This map shows the geographic impact of Richard Hildreth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Hildreth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Hildreth more than expected).

Fields of papers citing papers by Richard Hildreth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Hildreth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Hildreth. The network helps show where Richard Hildreth may publish in the future.

Co-authorship network of co-authors of Richard Hildreth

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Hildreth. A scholar is included among the top collaborators of Richard Hildreth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Hildreth. Richard Hildreth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhang, Aiping, Richard Hildreth, & Anamaris M. Colberg‐Poley. (2013). Human Cytomegalovirus Inhibits Apoptosis by Proteasome-Mediated Degradation of Bax at Endoplasmic Reticulum-Mitochondrion Contacts. Journal of Virology. 87(10). 5657–5668. 36 indexed citations
2.
Hildreth, Richard, Aiping Zhang, Hui‐Ling Chen, et al.. (2012). Viral mitochondria-localized inhibitor of apoptosis (UL37 exon 1 protein) does not protect human neural precursor cells from human cytomegalovirus-induced cell death. Journal of General Virology. 93(11). 2436–2446. 4 indexed citations
3.
Morisot, Sebastien, Alan S. Wayne, Osnat Bohana‐Kashtan, et al.. (2010). High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia. 24(11). 1859–1866. 37 indexed citations
4.
Bohana‐Kashtan, Osnat, Sebastien Morisot, Richard Hildreth, et al.. (2009). Selective Reduction of Graft-versus-Host Disease-Mediating Human T Cells by Ex Vivo Treatment with Soluble Fas Ligand. The Journal of Immunology. 183(1). 696–705. 25 indexed citations
5.
Klase, Zachary, Rafael Winograd, Lawrence Carpio, et al.. (2009). HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology. 6(1). 18–18. 131 indexed citations
6.
Alder, Jonathan K., Robert W. Georgantas, Richard Hildreth, et al.. (2008). Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo. The Journal of Immunology. 180(8). 5645–5652. 169 indexed citations
7.
Morisot, Sebastien, Alan S. Wayne, Osnat Bohana‐Kashtan, et al.. (2008). Leukemia Stem Cells (LSCs) Are Frequent in Childhood Precursor B Acute Lymphoblastic Leukemia (ALL).. Blood. 112(11). 1354–1354. 3 indexed citations
8.
Georgantas, Robert W., Richard Hildreth, Sebastien Morisot, et al.. (2007). CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control. Proceedings of the National Academy of Sciences. 104(8). 2750–2755. 397 indexed citations
9.
Alder, Jonathan K., Robert W. Georgantas, Richard Hildreth, & Curt I. Civin. (2006). 348. Kruppel-Like Factor 4 Regulates Proliferation of Human and Mouse Hematopoietic Stem-Progenitor Cells, but Is Not Essential for Mouse Hematopoietic Repopulation. Molecular Therapy. 13. S132–S133. 2 indexed citations
10.
Georgantas, Robert W., Richard Hildreth, Sebastien Morisot, Jonathan K. Alder, & Curt I. Civin. (2006). MicroRNA hsa-mir-155 Blocks Myeloid and Erythroid Differentiation of Human CD34+ Cells.. Blood. 108(11). 1337–1337. 1 indexed citations
11.
Hildreth, Richard, Robert W. Georgantas, Roshan M. Patel, et al.. (2006). MicroRNA hsa-mir-16 Contributes to Regulation of Myeloid Differentiation of Human CD34+ Cells.. Blood. 108(11). 1343–1343. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026